Financial Gravity Companies’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$37K Buy
+295
New +$36.8K 0.01% 343
2024
Q4
$45.1K Buy
+295
New +$49.8K 0.01% 303
2018
Q4
$319K Buy
+963
New +$307K 0.29% 56
2018
Q1
$318K Buy
1,162
+734
+171% +$228K 0.33% 52
2017
Q4
$149K Buy
+428
New +$137K 0.17% 116

Other funds holding BIIB

Financial Gravity Companies's BIIB Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in Biogen (BIIB) in Q2 2025: 295 shares worth $37K. The stake represents 0.01% of the portfolio and ranks #343 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in BIIB as recently as Q4 2024.

Financial Gravity Companies first reported a position in BIIB in Q4 2017 and has held it in 5 quarters since. The position peaked at $319K in Q4 2018. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Financial Gravity Companies held 295 shares of Biogen worth $37K as of Q2 2025.
  • Biogen was a new Financial Gravity Companies position in Q2 2025.
  • Biogen made up 0.01% of Financial Gravity Companies's portfolio in Q2 2025, its #343 holding.
  • Financial Gravity Companies first reported a position in Biogen in Q4 2017 and has held it in 5 quarters since.
  • Financial Gravity Companies's Biogen position peaked at $319K in Q4 2018.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.